Teva is looking to fill any gap when it comes to the new biologics for chronic migraine with the company confirming TGA approval of AJOVY (fremanezumab) ahead of this week's PBAC meeting. …
Latest Video
New Stories
-
Biogen appoints senior leader as new managing director
January 22, 2020 - - Latest News -
New leadership for the Department of Health
January 22, 2020 - -
AusBiotech opens 2020 CEO Industry Position Survey
January 22, 2020 - - Latest News -
PHARMAC protest: Couple tow coffin across NZ
January 22, 2020 - - Latest News -
Lundbeck makes global climate change A-list
January 22, 2020 - - Latest News -
PBAC Executive: It meets when it meets
January 22, 2020 - - Latest News -
Guild rejects hospital call for extended dispensing powers
January 21, 2020 - - Latest News